Fennec Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Fennec Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Fennec Pharmaceuticals Inc
Rating: 1.185444375
Author: Trendlyne DVM scores

Momentum Trap

about

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The comp...

10.48 0.04 (0.38%)

85.49% Gain from 52W Low

120.2K

XNAS Volume

XNAS 17 Jul, 2026 3:04 PM (EDT)

Low Financial Strength

11.1 / 100

Expensive Valuation

11.3 / 100

Technically Moderately Bullish

61.3 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 50%

6 analysts

Fennec Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Fennec Pharma Inc Live Stock Price Today, Share Analysis and Chart

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The comp...

85.49% Gain from 52W Low

SWOT Analysis

Fennec Pharma Inc Live Price Chart

Fennec Pharma Inc Live Price Chart